ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 61

Killer Immunoglobulin-like Receptors Are Associated with Ankylosing Spondylitis

Aimee Hanson1, International Genetics of Ankylosing Spondylitis Consortium (IGAS)2, Kim-Anh Lê Cao3, Tony J. Kenna4 and Matthew A. Brown2, 1The University of Queensland Diamantina Institute, Translational Research Instiute, Brisbane, Australia, Brisbane, Australia, 2Translational Genomics Group, Institute of Health and Biomedical Innovation, Queensland University of Technology, Translational Research Institute, Brisbane, Australia, Brisbane, Australia, 3Translational Research Instiute, The University of Queensland Diamantina Institute, Brisbane, Australia, 4Translational Research Institute, Translational Genomics Group, Institute of Health and Biomedical Innovation, Queensland University of Technology, Brisbane, Australia

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: Ankylosing spondylitis (AS), human leukocyte antigens (HLA) and statistics, Immunogenetics, KIR (Killer Ig like receptor)

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, November 13, 2016

Title: Genetics, Genomics and Proteomics - Poster I

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: Killer immunoglobulin-like receptors (KIRs) are expressed predominantly on the surface of natural killer (NK) cells and some T-cells and are important in regulating the inflammatory phenotype of these cell types. The 17 known KIR genes are arranged in variable content haplotypes that differ substantially in composition across the human population. Specific HLA subtypes act as KIR ligands, and the repertoire of HLA and KIR alleles carried has been shown to alter risk for autoimmune or infectious diseases by shifting activation thresholds of cytotoxic NK cells. We aimed to interrogate patterns in, and statistical interactions between, KIR genes and HLA alleles in a large population of individuals with ankylosing spondylitis (AS), in which HLA-B*27 in particular exerts a substantial genetic contribution to disease.

Methods: Gene dosages across KIR loci were imputed from Immunochip genotype data for 10464 AS cases and 15239 control HLA-typed individuals using the statistical package KIR*IMP. Differences in KIR gene content and haplotype composition were assessed, with additional consideration of HLA type used to investigate gene-gene interactions and co-occurrence patterns in cases and controls.

Results: We identified a statistical interaction between the HLA-Bw4 recognising KIR genes KIR3DL1 and KIR3DS1 and HLA-B*27 (a Bw4 type allele). Presence of the NK cell activating receptor KIR3DS1 increased risk of AS in HLA-B*27 positive individuals, but was protective in HLA-B*27 negative individuals (P interaction = 0.007). In contrast, inhibitory receptor KIR3DL1 exhibited the opposite pattern of association, with presence of the gene being protective in HLA-B27 positive individuals but risk predisposing in HLA-B*27 negative individuals (P interaction = 0.002). We observed a suggestive disease association with KIR locus variant rs775859 (P=2×10-5) and a significant interaction between the variant used to tag the presence of the KIR2DL5 gene and HLA-B*27 (P=3×10-4), with carriage of both KIR2DL5 and HLA-B27 increasing disease risk. Intriguingly, a significantly lower frequency of KIR2DL5 was also seen in HLA-B*27 positive controls relative to HLA-B27-ve controls (P=0.001, OR=0.81), indicative of evolutionary pressure against this co-occurrence. In HLA-B*27 negative individuals there was a strong interaction between the KIR2DL3 gene and HLA-C*12 (P interaction = 7.1×10-5).

Conclusion: Interactions between HLA-B*27 and specific KIR receptors may contribute to AS by altering the inflammatory activity of NK cells.


Disclosure: A. Hanson, None; I. G. O. A. S. C. (IGAS), None; K. A. Lê Cao, None; T. J. Kenna, None; M. A. Brown, None.

To cite this abstract in AMA style:

Hanson A, (IGAS) IGOASC, Lê Cao KA, Kenna TJ, Brown MA. Killer Immunoglobulin-like Receptors Are Associated with Ankylosing Spondylitis [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/killer-immunoglobulin-like-receptors-are-associated-with-ankylosing-spondylitis/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/killer-immunoglobulin-like-receptors-are-associated-with-ankylosing-spondylitis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology